| Literature DB >> 26482026 |
Griselle Hernández-Cancel1, Dámaris Suazo-Dávila2, Axel J Ojeda-Cruzado3, Desiree García-Torres4, Carlos R Cabrera5, Kai Griebenow6.
Abstract
BACKGROUND: This study provides fundamental information on the influence ofEntities:
Mesh:
Substances:
Year: 2015 PMID: 26482026 PMCID: PMC4617716 DOI: 10.1186/s12951-015-0134-0
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 10.435
Fig. 1Schematic model of BOD immobilized onto graphene oxide nanosheets (PDB-2XLL)
Zeta-potential values of graphene oxide after the oxidation process, native and glycosylated BOD, and bioconjugate formation
| Sample | Solvent | Z potential |
|---|---|---|
| GO | 0.1 M PBS pH 7.4 | −23 ± 1 |
| BOD | −6 ± 1 | |
| Dex-BOD | −4 ± 0.9 | |
| BOD-GO-A | −16 ± 1 | |
| BOD-GO-C | −15.5 ± 0.8 | |
| Dex-BOD-GO-C | −13.6 ± 0.6 |
Fig. 2X-ray photoelectron spectroscopy binding energy survey (a) and high resolution spectra of N 1s1/2 (b) and S 2p1/2 (c) binding energy region for GO, sulfo-NHS-GO, BOD, BOD-GO-A, and BOD-GO-C. All spectra were background corrected and vertically displaced for ease of visualization
Fig. 3FT-IR spectra of GO, BOD, and BOD-GO
Fig. 4Activation of dextran hexanoic acid with EDC/sulfo-NHS (a). Scheme representing the general reaction between BOD and activated dextran to obtain the glycoconjugate (b). BOD (PDB-2XLL): solvent accessible lysine residues are shown in red. Sulfo-NHS-Dextran: red oxygen, blue nitrogen, yellow sulfur, grey carbon
Fig. 5High-resolution X-ray photoelectron spectroscopy of N 1s1/2 (a) and S 2p1/2 (b) binding energy region acquired from dextran and dextran activated with sulfo-NHS. All spectra were background corrected and vertically displaced for ease of visualization
Comparison of catalytic parameters derived from the oxidation of ABTS by BOD
| Specific activity (U mg−1) |
|
|
| |
|---|---|---|---|---|
| BOD | 3618 ± 28 | 29.1 ± 0.6 | 385 ± 18 | 13.2 ± 0.5 |
| Dex-BOD | 1841 ± 25 | 26.8 ± 0.6 | 171 ± 10 | 6.4 ± 0.3 |
| Lyo-BOD | 1908 ± 23 | 25.2 ± 0.5 | 195 ± 11 | 7.8 ± 0.6 |
| BOD-GO-A | 3302 ± 29 | 30.2 ± 0.6 | 325 ± 23 | 10.7 ± 0.7 |
| BOD-GO-C | 2435 ± 28 | 27.8 ± 0.9 | 230 ± 12 | 8.3 ± 0.5 |
| Dex-BOD-GO-C | 1321 ± 27 | 28.4 ± 0.5 | 137 ± 8 | 4.8 ± 0.1 |
Fig. 6Near-UV CD spectra of BOD, Dex-BOD, Lyo-BOD in 0.1 M PBS pH 7.4 at 25 °C (a). Far-UV CD spectra of BOD, Dex-BOD, Lyo-BOD, BOD-GO-A, BOD-GO-C, and Dex-BOD-GO-C in 0.1 M PBS pH 7.4 at 25 °C (b). Estimates of the secondary structure calculated from the CD spectra using CDNN program (c). The data represented here was obtained by averaging three independent measurements (n = 3). The error bar represents the standard deviation
Fig. 7A typical FTIR-H/D exchange experiment for BOD, arrows highlight both the decreasing amide II band (N–H; 1550 cm−1) and the increasing amide II’ band (N–D; 1450 cm−1). a H/D exchange decay plots at 25 °C (pD 8.2) for BOD (filled circle), Dex-BOD (filled inverted triangle), BOD-GO-A (filled square), BOD-GO-C (filled diamond) and Dex-BOD-GO-C (filled triangle) (b)
Kinetic parameter derived from the H/D kinetic analysis
| A1 |
| A2 |
| A3 | ΔGmic (Kcal mol−1) | (ΔGmic)−1 (Kcal−1 mol) | |
|---|---|---|---|---|---|---|---|
| BOD | 0.479 | 1.062 | 0.192 | 0.0132 | 0.328 | 6.8 | 0.1472 |
| Dex-BOD | 0.336 | 0.1857 | 0.228 | 0.0067 | 0.415 | 940.1 | 0.0011 |
| BOD-GO-A | 0.483 | 1.049 | 0.259 | 0.0152 | 0.258 | 12.4 | 0.0805 |
| BOD-GO-C | 0.389 | 0.9721 | 0.155 | 0.0117 | 0.455 | 54.9 | 0.0182 |
| Dex-BOD-GO-C | 0.101 | 0.1257 | 0.104 | 0.006 | 0.783 | 1145.7 | 0.0009 |
Fig. 8Kinetics of thermoinactivation at 45 °C for BOD (filled circle), Dex-BOD (filled inverted triangle), BOD-GO-A (filled square), BOD-GO-C (filled diamond) and Dex-BOD-GO-C (filled triangle) in 0.1 M PBS pH 7.4
Kinetic parameters derived from the thermal inactivation experiment
| α1 |
| t1/2 (min) | α2 |
| t1/2 (min) | |
|---|---|---|---|---|---|---|
| BOD | 0.31 ± 0.02 | 0.19 ± 0.03 | 3.6 | 0.67 ± 0.01 | 0.0029 ± 0.0002 | 239.0 |
| Dex-BOD | 0.69 ± 0.01 | 0.13 ± 0.02 | 5.3 | 0.30 ± 0.02 | 0.0016 ± 0.0001 | 433.2 |
| BOD-GO-A | 0.29 ± 0.02 | 0.18 ± 0.03 | 3.9 | 0.69 ± 0.1 | 0.0035 ± 0.0002 | 198.0 |
| BOD-GO-C | 0.33 ± 0.02 | 0.20 ± 0.03 | 3.5 | 0.65 ± 0.02 | 0.0038 ± 0.0002 | 182.4 |
| Dex-BOD-GO-C | 0.73 ± 0.03 | 0.15 ± 0.09 | 4.6 | 0.26 ± 0.01 | 0.0016 ± 0.0002 | 330.7 |